Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
British Journal of Haematology|August 10, 2007
Lenalidomide-induced myelosuppression is associated with renal dysfunction: adverse events evaluation of treatment-naïve patients undergoing front-line lenalidomide and dexamethasone therapyRuben Niesvizky, Tara Naib, Paul J Christos, et al.British Journal of Haematology|October 28, 2008
Atypical serum immunofixation patterns frequently emerge in immunomodulatory therapy and are associated with a high degree of response in multiple myelomaTomer Mark, David Jayabalan, Morton Coleman, et al.American Journal of Hematology|July 21, 2010
Clarithromycin (Biaxin)-lenalidomide-low-dose dexamethasone (BiRd) versus lenalidomide-low-dose dexamethasone (Rd) for newly diagnosed myelomaFrancesca Gay, S Vincent Rajkumar, Morton Coleman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2026
Selinexor Plus Ruxolitinib in JAK Inhibitor-Naïve Myelofibrosis: Phase 3 SENTRY TrialPrithviraj Bose, Haris Ali, Haifa Kathrin Al-Ali, et al.Blood|November 9, 2007
BiRD (Biaxin [clarithromycin]/Revlimid [lenalidomide]/dexamethasone) combination therapy results in high complete- and overall-response rates in treatment-naive symptomatic multiple myelomaRuben Niesvizky, David S Jayabalan, Paul J Christos, et al.Leukemia & Lymphoma|February 15, 2021
Sequential intensive chemotherapy followed by autologous or allogeneic transplantation for refractory lymphomaNina Orfali, Yuliya Jhanwar, Calvin Koo, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 7, 2016
Post-Transplant Outcomes in High-Risk Compared with Non-High-Risk Multiple Myeloma: A CIBMTR AnalysisEmma C Scott, Parameswaran Hari, Manish Sharma, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 30, 2016
Allogeneic Transplantation for Relapsed Waldenström Macroglobulinemia and Lymphoplasmacytic LymphomaRobert F Cornell, Veronika Bachanova, Anita D'Souza, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 24, 2018
Revised International Staging System Is Predictive and Prognostic for Early Relapse (<24 months) after Autologous Transplantation for Newly Diagnosed Multiple MyelomaSathish Gopalakrishnan, Anita D'Souza, Emma Scott, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 25, 2018
Staging Systems for Newly Diagnosed Myeloma Patients Undergoing Autologous Hematopoietic Cell Transplantation: The Revised International Staging System Shows the Most Differentiation between GroupsEmma C Scott, Parameswaran Hari, Sathish Kumar, et al.Pageof 4